Drug Trafficker and Fraudster Gets 10-Year U.S. Ban.
Published Date: 3/13/2025
Notice
Summary
Harpreet Singh is banned for 10 years from importing any drugs into the U.S. because he was convicted of serious crimes like drug trafficking and fraud. He didn’t respond to the FDA’s notice, so the ban starts on March 13, 2025. Singh can apply to end this ban anytime, but it won’t be easy or quick.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 2 costs, 1 mixed.
10‑Year Import Ban for Harpreet Singh
Harpreet Singh is debarred for 10 years from importing or offering for import any drug into the United States, effective March 13, 2025. The debarment is based on his May 21, 2024 felony convictions for offenses including conspiracy to possess with intent to distribute several controlled substances, fraudulent importation, money laundering, and obstruction of justice.
Prohibition on Acting with or Directing Singh
Beginning March 13, 2025, under section 301(cc) of the FD&C Act it is a prohibited act to import or offer for import any drug 'by, with the assistance of, or at the direction of' Harpreet Singh. Businesses or individuals cannot lawfully rely on Mr. Singh to import drugs without risking a prohibited‑act violation.
Right to Apply to End Debarment; Public Filing Rules
Mr. Singh may submit an application to terminate his debarment at any time under section 306(d)(1) of the FD&C Act. Applications submitted electronically to https://www.regulations.gov will be posted publicly unchanged, while confidential information can be submitted only as a written/paper submission following the FDA's instructions for confidential submissions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Previous / Next Documents
Previous: 2025-04027, Atlantic Highly Migratory Species; Schedules for Atlantic Shark Identification Workshops and Protected Species Safe Handling, Release, and Identification Workshops
If you’re a fisherman or shark dealer with federal permits, you’ve got to attend free workshops in spring 2025 to keep your permits valid. These workshops teach you how to identify sharks and handle protected species safely. They’re happening in several East Coast spots and even online for recertification—no extra cost, just mark your calendar!
Next: 2025-04029, Alnashir Alibhai Punjani: Final Debarment Order
Alnashir Alibhai Punjani is banned for 5 years from importing any drugs into the U.S. because he was convicted of a serious crime involving unapproved drugs. He didn’t respond to the FDA’s notice, so the ban starts on March 13, 2025. Punjani can apply to end the ban anytime, but must follow strict rules to keep personal info private.